JHS Svendgaard Laboratories — 360° view

JHS Svendgaard Laboratories, a company in the Personal Care industry, reported revenue of ₹22 crore and net profit of ₹0.51 crore for the September 2026 quarter.

JHS Svendgaard Laboratories (NSE: JHS-BE) closed at ₹8.19 on 20 Nov 2026, down 26.6% over the past year. Its market capitalisation is ₹72 crore.

Share price
₹8.19 (20 Nov 2026)
Market cap
₹72 Cr (20 Nov 2026)
Revenue
₹22 Cr (September 2026 quarter)
Net profit
₹1 Cr (September 2026 quarter)
ROCE
-0.84% (FY26)
ROE
-1.17% (FY26)
Book value
₹20.2 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹13.68 / ₹6.15 (20 Nov 2026)
1-year return
-26.6% (to 20 Nov 2026)
Sector
Fast Moving Consumer Goods
Industry
Personal Care
Symbol
NSE: JHS-BE

Incorporated in 1997, JHS Svendgaard Laboratories Ltd does manufacturing of oral and dental products for national and international brands

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.